Company · CIK 0001211583 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
FENNEC PHARMACEUTICALS INC. · FENC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 SForm 4 → | Sep 16, 4:05 pm EDT | Marco Maria BrugheraDirector | 15,545 | $10.29 | $159,958 | 0 | −100% | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 16, 4:05 pm EDT | Marco Maria BrugheraDirector | 15,545 | $2.11 | $32,800 | 15,545 | — | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 1, 4:05 pm EDT | Rosty RaykovOther | 10,000 | $12.11 | $121,100 | 124,411 | −7.44% | 10b5-1 |
| Aug 31, 2026 AForm 4 → | Sep 1, 4:05 pm EDT | Rosty RaykovOther | 2,778 | — | — | 134,411 | — | 10b5-1 |
| Aug 31, 2026 SForm 4 → | Aug 31, 8:15 pm EDT | Pierre Sargis SayadChief Medical Officer | 12,000 | $12.18 | $146,160 | 9,519 | −55.8% | |
| Aug 31, 2026 AForm 4 → | Aug 31, 8:15 pm EDT | Pierre Sargis SayadChief Medical Officer | 168 | — | — | 21,519 | — | |
| Aug 31, 2026 AForm 4 → | Aug 31, 8:13 pm EDT | Terry L EvansChief Commercial Officer | 168 | — | — | 21,519 | — | |
| Aug 31, 2026 AForm 4 → | Aug 31, 8:12 pm EDT | Christiana Marie CioffiChief Strategy Officer | 156 | — | — | 24,644 | — | |
| Aug 31, 2026 AForm 4 → | Aug 31, 8:10 pm EDT | Jeffrey S. HackmanChief Executive Officer, Director | 1,159 | — | — | 66,302 | — | |
| Aug 31, 2026 AForm 4 → | Aug 31, 8:09 pm EDT | Robert AndradeCHIEF FINANCIAL OFFICER | 1,703 | — | — | 241,306 | — | |
| Aug 28, 2026 MForm 4 → | Aug 28, 5:42 pm EDT | Robert AndradeCHIEF FINANCIAL OFFICER | 21,928 | $5.10 | $111,833 | 239,603 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 16, 4:05 pm EDT | Marco Maria BrugheraDirector | 15,545 | — | — | 220,000 | — | 10b5-1 |
| Aug 28, 2026 MForm 4 → | Aug 28, 5:42 pm EDT | Robert AndradeCHIEF FINANCIAL OFFICER | 21,928 | — | — | 779,330 | — | 10b5-1 |